125 related articles for article (PubMed ID: 14666699)
1. Deregulation of D-type cyclins in uterine cancers. Cyclin D1/D3 is differentially expressed in cervical cancer.
Skomedal H; Forus A; Holm R
Anticancer Res; 2003; 23(5A):3929-35. PubMed ID: 14666699
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D3 immunoreactivity is an independent predictor of survival in laryngeal squamous cell carcinoma.
Pruneri G; Pignataro L; Valentini S; Fabris S; Maisonneuve P; Carboni N; Pece S; Capra M; Del Curto B; Neri A; Viale G
Clin Cancer Res; 2005 Jan; 11(1):242-8. PubMed ID: 15671552
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of cell cycle regulatory proteins in benign and malignant bone and soft tissue neoplasms.
Bui MM; Bagui TK; Boulware DC; Letson DG; Nasir A; Kaiser HE; Pledger WJ; Coppola D
In Vivo; 2007; 21(5):729-37. PubMed ID: 18019405
[TBL] [Abstract][Full Text] [Related]
4. Cyclin alterations in giant cell tumor of bone.
Kauzman A; Li SQ; Bradley G; Bell RS; Wunder JS; Kandel R
Mod Pathol; 2003 Mar; 16(3):210-8. PubMed ID: 12640100
[TBL] [Abstract][Full Text] [Related]
5. Retinoid targeting of different D-type cyclins through distinct chemopreventive mechanisms.
Ma Y; Feng Q; Sekula D; Diehl JA; Freemantle SJ; Dmitrovsky E
Cancer Res; 2005 Jul; 65(14):6476-83. PubMed ID: 16024653
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 gene expression in human cervical neoplasia.
Nichols GE; Williams ME; Gaffey MJ; Stoler MH
Mod Pathol; 1996 Apr; 9(4):418-25. PubMed ID: 8729983
[TBL] [Abstract][Full Text] [Related]
7. Estrogen-induced cyclin D1 and D3 gene expressions during mouse uterine cell proliferation in vivo: differential induction mechanism of cyclin D1 and D3.
Geum D; Sun W; Paik SK; Lee CC; Kim K
Mol Reprod Dev; 1997 Apr; 46(4):450-8. PubMed ID: 9094091
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI rats.
Weroha SJ; Li SA; Tawfik O; Li JJ
Carcinogenesis; 2006 Mar; 27(3):491-8. PubMed ID: 16311245
[TBL] [Abstract][Full Text] [Related]
9. Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma.
Flørenes VA; Faye RS; Maelandsmo GM; Nesland JM; Holm R
Clin Cancer Res; 2000 Sep; 6(9):3614-20. PubMed ID: 10999753
[TBL] [Abstract][Full Text] [Related]
10. Cyclin D1 and D3 associate with the SCF complex and are coordinately elevated in breast cancer.
Russell A; Thompson MA; Hendley J; Trute L; Armes J; Germain D
Oncogene; 1999 Mar; 18(11):1983-91. PubMed ID: 10208420
[TBL] [Abstract][Full Text] [Related]
11. Expression and gene amplification of primary (A, B1, D1, D3, and E) and secondary (C and H) cyclins in colon adenocarcinomas and correlation with patient outcome.
Bondi J; Husdal A; Bukholm G; Nesland JM; Bakka A; Bukholm IR
J Clin Pathol; 2005 May; 58(5):509-14. PubMed ID: 15858123
[TBL] [Abstract][Full Text] [Related]
12. Cyclins D1, D3, E, and A in vulvar carcinoma patients.
Knopp S; Bjørge T; Nesland JM; Tropé C; Holm R
Gynecol Oncol; 2005 Jun; 97(3):733-9. PubMed ID: 15894358
[TBL] [Abstract][Full Text] [Related]
13. Expression and possible role of cyclin D3 in human pancreatic adenocarcinoma.
Ito Y; Takeda T; Wakasa K; Tsujimoto M; Matsuura N
Anticancer Res; 2001; 21(2A):1043-8. PubMed ID: 11396138
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D3 immunoreactivity in gastrointestinal stromal tumors is independent of cyclin D3 gene amplification and is associated with nuclear p27 accumulation.
Pruneri G; Mazzarol G; Fabris S; Del Curto B; Bertolini F; Neri A; Viale G
Mod Pathol; 2003 Sep; 16(9):886-92. PubMed ID: 13679452
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of cyclin D1 in epithelial ovarian cancers.
Worsley SD; Ponder BA; Davies BR
Gynecol Oncol; 1997 Feb; 64(2):189-95. PubMed ID: 9038263
[TBL] [Abstract][Full Text] [Related]
16. Improved diagnostic segregation of mantle cell lymphoma by determination of cyclin D1/D3 expression ratio in formalin-fixed tissue.
Mangseth K; Helgeland L; Klos J; Molven A; Vintermyr OK
Diagn Mol Pathol; 2009 Sep; 18(3):150-5. PubMed ID: 19704260
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of cell-cycle proteins in gastric precancerous lesions.
Anagnostopoulos GK; Stefanou D; Arkoumani E; Karagiannis J; Paraskeva K; Chalkley L; Habilomati E; Tsianos E; Agnantis NJ
J Gastroenterol Hepatol; 2008 Apr; 23(4):626-31. PubMed ID: 18397488
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1).
Lopez-Beltran A; Luque RJ; Alvarez-Kindelan J; Quintero A; Merlo F; Carrasco JC; Requena MJ; Montironi R
Eur Urol; 2004 May; 45(5):606-12. PubMed ID: 15082203
[TBL] [Abstract][Full Text] [Related]
19. Expression of cyclin genes in human gastric cancer and in first degree relatives.
Yu J; Miehlke S; Ebert MP; Szokodi D; Wehvnignh B; Malfertheiner P; Ehninger G; Bayerdoerffer E
Chin Med J (Engl); 2002 May; 115(5):710-5. PubMed ID: 12133540
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous deregulation of p16 and cyclin D1 genes in pancreatic ductal adenocarcinoma: a combined immunohistochemistry and image analysis study based on tissue microarrays.
Tsiambas E; Karameris A; Gourgiotis S; Salemis N; Athanassiou AE; Karakitsos P; Papalois A; Merikas E; Kosmidis P; Patsouris E
J BUON; 2007; 12(2):261-7. PubMed ID: 17600882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]